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Abstract
As extracorporeal membrane oxygenation increases the left ventricular afterload, a successful treatment plan should
include strategies to address this issue. One promising approach to do so is the addition of a second device for active left
ventricular unloading. However, this relatively new approach is currently only based on retrospective data. This article
summarizes the current perspectives on this approach, provides recommendations for its application, and highlights the need
for randomized data on this topic.
Keywords: extracorporeal membrane oxygenation, percutaneous mechanical circulatory support, cardiogenic shock, heart
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Why?
When extracorporeal membrane oxygenation (ECMO) is
used to retrogradely perfuse the aorta, the left ventricle (LV)
afterload increases. Although some patients can compensate
quite well, others do not. Thus, myocardial recovery can be
hampered, which might lead to fatal complications, such as an
LV thrombus formation. Consequently, we need to think
about the increase in LV afterload in ECMO patients. Thus,
clinical teams that manage ECMO-supported patients must
prepare protocols to address the increase in LV afterload,
deciding on when an intervention is necessary or not.

How?
Patients receiving ECMO support for cardiogenic shock
experience an increase in wedge pressure, a surrogate marker
for LV end-diastolic pressure. Many institutions will add an
Impella device (Abiomed) to decrease and normalize LV
pressures in such cases. The combined Impella and ECMO

support (ECMELLA) actively unloads the LV, thereby
preserving or enabling myocardial recovery. Although
prospective, randomized data are lacking, some observational
studies on using ECMELLA are available. In a recent study,
more than 500 propensity score-matched patients were
compared, indicating lower mortality in the ECMELLA
cohort.1 However, ECMELLA was also associated with more
complications in that study. The rationale for this association
is that a second mechanical circulatory support device requires
secondary vascular access, so there is a higher risk of bleeding
and ischemia. Thus, more work on decreasing the risk of
complications with ECMELLA is needed, which might
improve the benefit-risk ratio of this approach. For example,
using ultrasound for vascular access alongside meticulous
follow-up care might reduce the risk of severe bleeding or
ischemic events.
In addition to the Impella device, other options for LV
unloading exist. A Canadian meta-analysis showed that an
intra-aortic balloon pump for LV unloading in ECMO patients
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might also work, and this therapy combination may contribute
to counteracting the increase in LV afterload.2 The best
strategy for the patient depends on the hospital setting and the
health care team’s familiarity and expertise with the specific
percutaneous device.

When?
While early LV unloading may improve outcomes, using
ECMELLA could also be seen as a bailout strategy. In the
previously mentioned propensity score-matched study, the
data implied that the use of ECMELLA is better earlier than
later. In this regard, a recently completed follow-up analysis
reviewed ECMELLA-supported patients receiving both
devices within 24 hours and indicated that those with early LV
unloading had a lower mortality risk than patients with a
delayed LV unloading. In fact, the later the Impella was
implanted after the ECMO, the higher the risk of mortality.
Thus, this supports the use of LV unloading as a primary
(early) treatment strategy rather than as a bailout strategy.

Where?
The LV unloading can be done in the catheterization
laboratory or the operating room. Once again, the best place
depends on the individual hospital setting and team expertise.
Some hospitals use different strategies to address the increase
in LV afterload, eg by centrally cannulating the patient on
ECMO or using left atrial venoarterial (LAVA) ECMO. Other
hospitals are familiar with the Impella device and complete the
procedure in a catheterization laboratory. These preferences
will primarily determine the best place to perform the LV
unloading. The most important takeaway is that the increase
in LV afterload is recognized as a relevant problem and that
there is a structured way to assess and, if needed, to address it.
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Conclusion
Because ECMO support increases the LV afterload, a
successful treatment plan must include strategies to address
this, tailored to the local expertise and resources. An
interdisciplinary approach is necessary, as multiple experts
need to work together to yield favorable results. ECMELLA
support should be used earlier rather than later; however, this
recommendation is based on retrospective data. Therefore,
inherent bias does exist. Future prospective, randomized trials
are planned.
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